None listed
Conditions
Interventions
Medical Device : Participants has dyspnea at the outset of treatment are randomly assigned to the conventional oxygen therapy or HFNC therapy groups. Subsequently, treatment is administered according
, and PaO2 80 mmHg. To verify that the correct amount of oxygen is delivered to the tissues, the SpO2 is measured once every 30 minutes, for a total of 3 measurements. To verify tissue oxygenation, th
Sponsors
Yonsei University Health System, Gangnam Severance Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - 19 years and older - Patients having Heart failure (according to the AHA/ESC guideline) - X-ray confirmation of acute pulmonary edema
Exclusion criteria
Exclusion criteria: - Presence of serious congenital heart condition(s) - Poor chance of survival due to pre-existing condition(s) - In need of immediate invasive trachea management, as O2 supply alone would not be helpful due to the severity of the symptoms - On-going dialysis due to renal disease - Reluctance to provide consent due to pre-existing condition(s) or DNR status - Cases of transfer from another healthcare institution following the stabilization of symptoms - Pregnant women - Age less than 19 years - Inability to provide treatment consent due to the severity of respiratory failure, or the absence of legal caregivers to authorize treatment - Decline in consciousness (GCS < 8)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| compare the changes in arterial blood gas levels;compare the changes in breathing rates | — |
Secondary
| Measure | Time frame |
|---|---|
| the rates of intubation and ICU admission | — |
Countries
Korea, Republic of
Contacts
Public ContactDong Ryul Ko
Yonsei University Health System, Gangnam Severance Hospital
Outcome results
None listed